Patient and tumour characteristics
| Gender no (%) | |
| Male | 50 (58.8%) |
| Female | 35 (41.2%) |
| Age median (range) | 68.4 (23.8–100.0) |
| Site of tumour | |
| Upper eyelid | 19 (22.4%) |
| Lower eyelid | 12 (14.1%) |
| Medial canthus | 9 (10.6%) |
| Lateral canthus | 3 (3.5%) |
| Brow | 6 (7.1%) |
| Eyelid lesions involving orbit | 34 (40.0%) |
| Temple | 1 (1.2%) |
| Multiple lesions | 1 (1.2%) |
| Laterality | |
| Left | 52 (61.2%) |
| Right | 32 (37.6%) |
| Bilateral | 1 (1.2%) |
| Treatment | |
| Eye-sparing surgery | 72 (84.7%) |
| Exenteration | 13 (15.3%) |
| Adjuvant therapy | |
| Radiotherapy | 6 (7.1%) |
| Chemotherapy | 2 (2.4%) |
| Chemoradiation | 1 (1.2%) |
| PNI 28 29 | |
| Clinical PNI | 3 (3.5%) |
| Pathological PNI | 6 (7.1%) |
| Differentiation | |
| Well differentiated | 9 (10.6%) |
| Moderately differentiated | 26 (30.6%) |
| Poorly differentiated | 19 (22.4%) |
| Report not avaliable | 31 (36.5%) |
| Sign of ocular area at present | |
| Primary | 60 (70.6%) |
| Recurrence | 25 (29.4%) |
| N at presentation | |
| N0 | 72 (84.7%) |
| N1 | 13 (15.3%) |
| M at presentation | |
| M0 | 84 (98.8%) |
| M1 | 1 (1.2%) |
PNI, perineural invasion.